Identification of stage biomarkers for human African trypanosomiasis

DN Amin, DM Ngoyi, GM Nhkwachi, M Palomba, M Rottenberg, P Büscher, K Kristensson, W Masocha

    Onderzoeksoutput: Bijdrage aan tijdschriftA1: Web of Science-artikel

    Uittreksel

    Human African trypanosomiasis (HAT), caused by infection with sub-species of Trypanosoma brucei (T. b.), manifests as a hemolymphatic stage followed by an encephalitic stage. The distinction of the two stages needs improvement as drugs used for the late stage are highly toxic. Transcripts encoding 16 secreted proteins differentially expressed in the brains of mice at late stage T. b. brucei infection when the early stage drug suramin is no longer effective and different to immunoglobulins, chemokines, and cytokines, were selected by microarray analysis. Lipocalin 2 and secretory leukocyte peptidase inhibitor (SLPI) mRNA showed the highest differential expression in mice. These transcripts were also upregulated in brains from infected rats. Lipocalin 2 was increased in cerebrospinal fluid (CSF) from rats during late stage T. b. brucei infection. Protein levels of lipocalin 2, SLPI, and the chemokine CXCL10 were found increased in CSF from Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense late stage HAT compared to early stage
    TaalEngels
    TijdschriftAmerican Journal of Tropical Medicine and Hygiene
    Volume82
    Exemplaarnummer6
    Pagina's (van-tot)983-990
    Aantal pagina's8
    ISSN0002-9637
    DOI's
    StatusGepubliceerd - 2010

    Trefwoorden

    • B780-tropische-geneeskunde

    Vingerafdruk Bekijk de onderzoeksthema's van 'Identification of stage biomarkers for human African trypanosomiasis'. Samen vormen ze een unieke vingerafdruk.

    Dit citeren